RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Investors are looking forward to Murphy USA (NYSE:MUSA)'s fourth-quarter and full-year 2024 financial report, which is ...

Investing gives you the opportunity to grow your money, to help you get the most out of life, whatever goals you have in mind ...

RBC Capital analysts reaffirmed their Outperform rating on the stock in a note Tuesday, emphasizing that President Trump's recent executive order on wind leasing and permitting is unlikely to have a ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

Justin Jewell has taken a role as global investment manager at Ninety One after leaving RBC BlueBay last August.

Each year, RBC supports thousands of students from different educational backgrounds in exploring various career paths within ...

RBC Capital analyst Gerard Cassidy maintained a Buy rating on Regions Financial (RF – Research Report) on January 17 and set a price target of ...

TIPS keep looking better and better. So-called TIPS bonds — the acronym stands for “Treasury inflation-protected securities” — are the only asset legally protected against the risks of ...

The group joining RBC's New York City office, led by advisors formerly affiliated with First Republic, gives it an additional ...

Long-term US Treasury yields have climbed so quickly that a prominent bear has said it’s time to take some chips off the table.

We recently compiled a list of the 13 AI News and Ratings on Wall Street’s Radar. In this article, we are going to take a ...